Exelixis Inc Debt Securities, Available-for-sale, Realized Gain (Loss)
Exelixis Inc (EXEL) reported Debt Securities, Available-for-sale, Realized Gain (Loss) of $0 for the 3-month period ending 2020-07-03, per its 10-Q filed 2020-08-06.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss · last filed 2020-08-06
- Exelixis Inc debt securities, available-for-sale, realized gain (loss) for the quarter ending 2020-07-03 was $0.00.
- Exelixis Inc debt securities, available-for-sale, realized gain (loss) for the quarter ending 2020-04-03 was $0.00.
- Exelixis Inc debt securities, available-for-sale, realized gain (loss) for the quarter ending 2019-09-27 was $0.00.
- Exelixis Inc debt securities, available-for-sale, realized gain (loss) for the quarter ending 2019-06-28 was $0.00.
- Exelixis Inc debt securities, available-for-sale, realized gain (loss) for fiscal 2016 was $0.00.
- Exelixis Inc debt securities, available-for-sale, realized gain (loss) for fiscal 2016 was $0.00.
| Period end | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2020-07-03 | $0.00 10-Q · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | ||
| 2020-04-03 | $0.00 10-Q · filed 2020-05-05 | |||
| 2019-09-27 | $0.00 10-Q · filed 2019-10-30 | $0.00 derived: sum of 2 quarters · filed 2020-08-06 | $0.00 10-Q · filed 2019-10-30 | |
| 2019-06-28 | $0.00 10-Q · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | ||
| 2019-03-29 | $0.00 10-Q · filed 2020-05-05 | |||
| 2018-09-28 | $0.00 10-Q · filed 2019-10-30 | $0.00 derived: sum of 2 quarters · filed 2019-10-30 | $0.00 10-Q · filed 2019-10-30 | |
| 2018-06-29 | $0.00 10-Q · filed 2019-07-31 | $0.00 10-Q · filed 2019-07-31 | ||
| 2018-03-30 | $0.00 10-Q · filed 2019-05-01 | |||
| 2017-09-29 | $0.00 10-Q · filed 2018-11-01 | $0.00 10-Q · filed 2018-11-01 | ||
| 2016-12-30 | $0.00 10-K · filed 2019-02-22 | |||
| 2016-01-01 | $0.00 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |